The development and spread of antibiotic resistance in bacteria is a universal threat to both
humans and animals that is generally not preventable but can nevertheless be controlled, …

The first European isolate of meticillin-resistant Staphylococcus aureus (MRSA) was
detected in 1960. Since then MRSA has become a leading cause of nosocomial infections …

Vancomycin is a glycopeptide antibiotic used for the treatment of Gram-positive bacterial
infections. Traditionally, it has been used as a drug of last resort; however, clinical isolates of …

The proliferation of large-scale DNA-sequencing projects in recent years has driven a
search for alternative methods to reduce time and cost. Here we describe a scalable, highly …

Methicillin resistance in Staphylococcus aureus has been associated with alterations in the
penicillin-binding proteins (PBPs). An intriguing property of all methicillin-resistant …

Epidemiological studies of the naturally transformable bacterial pathogen Streptococcus
pneumoniae have previously been confounded by high rates of recombination. Sequencing …

Over the past two decades, vancomycin has been considered the antibiotic of choice for
methicillin-resistant Staphylococcus aureus (MRSA) infections. Indeed, multidrug-resistant …

Septic shock caused by a diverse group of bacterial pathogens is a serious human disease.
Recognition of bacterial envelope constituents is one mechanism used by mammalian cells …

The spread of multidrug-resistant Staphylococcus aureus (MRSA) strains in the clinical
environment has begun to pose serious limits to treatment options. Yet virtually nothing is known …

Nongrowing bacteria evade the bactericidal activity of βbT-lactam antibiotics. We sought to
determine if slow growth rate also alters bactericidal activity. The bactericidal activity of two …